Vertex Announces Positive Phase III Data for Hepatitis Drug
The New York Times reports that about 75 percent of patients taking telaprevir in combination with existing hepatitis C drugs were essentially cured of the virus, compared to 44 percent on standard therapy alone.
Read more »Find Out Which Companies Are Presenting at OneMedForum New York 2010
OneMedPlace has announced the first 38 companies to be presenting at the OneMedForum New York 2010 investor conference on June 29-30.
Read more »Putting a Common Sleep Disorder to Bed
Millions of Americans suffer from sleep apnea, a disorder in which the patient repeatedly stops breathing during sleep.
Read more »Pharmaceutical Companies Eye India
On May 21, Abbott Laboratories announced that it would purchase Piramal Healthcare, a branded generics company based in India, for $3.72 billion.
Read more »Not a Drop to Drink
As we brush our teeth, take our long showers, and drink our eight glasses a day, it’s easy to forget that nearly one billion people in the world don’t have access to clean water.
Read more »Biomaterials, Implants
The company is a medical device company that has developed a technological platform to carry out biomaterial surface modifications to […]
Read more »Physiological Monitoring
The company is a medical device company that has developed a technological platform for the development of advanced physiological monitoring […]
Read more »Thrombosis, Diagnostics
The company is a medical devices company that has developed a technological platform to determine an individual’s susceptibility to thrombosis, […]
Read more »Aesthetics, Acne
The company is a medical devices company that is developing an over-the-counter instrument that delivers ultrasound energy to skin glands, […]
Read more »